Effect of methotrexate hold on COVID-19 vaccine response in the patients with autoimmune inflammatory disorders: A systematic review and meta-analysis

M Imran, S Ali, AA Ibrahim, A Amjad, A Tanveer… - Clinical …, 2024 - Springer
Immunosuppressants, such as methotrexate (MTX), can suppress the COVID-19 vaccine
response in patients with autoimmune diseases. Thus, this study aims to evaluate the effects …

[HTML][HTML] Older age, a high titre of neutralising antibodies and therapy with conventional DMARDs are associated with protection from breakthrough infection in …

A Picchianti-Diamanti, A Navarra, A Aiello, B Laganà… - Vaccines, 2023 - mdpi.com
Objectives: We aimed to analyse the incidence and severity of breakthrough infections (BIs)
in rheumatoid arthritis (RA) patients after a COronaVIrus Disease 2019 (COVID-19) …

Breakthrough SARS-CoV-2 infection and disease flares in patients with rheumatoid arthritis: result from COVAD e-survey study

CS Santos, JP Chen, E Nikiphorou, CW Tseng… - Rheumatology …, 2024 - Springer
COVID-19 has been suggested as a possible trigger of disease flares in patients with
rheumatoid arthritis (RA). However, factors associated with disease flares remain unknown …

Live Attenuated Vaccine Administration in Children Treated With Methotrexate or Dupilumab

JR Hughes, S Mehrmal, S Habib… - Pediatric …, 2024 - Wiley Online Library
Background and Objectives A wholesale recommendation against use of live virus vaccines
in patients treated with any medication classified as an immunosuppressant has been based …

[HTML][HTML] Investigation of IgG Titers in Hemodialysis Patients and Controls Following Administration of the COVID-19 Vaccine

M Jozpanahi, M Moharrer, P Mahmoudi… - The International …, 2023 - tinnitusjournal.com
Introduction: End-Stage Renal Disease (ESRD) patients necessitate dialysis when kidney
transplantation is not feasible. Hemodialysis patients exhibit higher mortality rates compared …